Podcast #64 MedMen Enterprises

“A New Cannabis Company for a New Consumer”

The definition of the cannabis consumer is changing and so is the business of the industry. At the forefront of this new wave of thinking is premium cannabis Company MedMen Enterprises (CSE: MMEN, Forum). 

“Breaking the stoner stereotype” to bring marijuana to the mainstream is its mission statement and it’s doing so with 13 operating dispensaries across the United States, employing more than 800 people. The Company listed on the Canadian Securities Exchange on May 29^th and before the listing, it was valued at $1.65 billion (US) by investors, making it the first cannabis “unicorn” Company based in the U.S.

As consumption becomes legal in more and more states, it also becomes a more conventional means to treat medical issues. In states where cannabis is legal for recreational purchases, consumers can buy everything from buds, edibles, creams. sprays, drops and even dog treats. The Company also uses a vertically-integrated business model in states that allow it.

MedMen was co-founded in 2010 by CEO Adam Bierman and COO Andrew Modlin. In March 2018, the Company announced its cross-border, joint-venture partnership with Cronos Group called MedMen Canada. This JV plans to open stores across Canada, develop products and retail facilities for the recreational market.

Stockhouse caught up with Adam Bierman to talk about MedMen’s debut on the CSE and what it means for the Company and how it is redefining the cannabis shopping experience.